Skip to content

The efficacy of intra-articular Ropivacaine for relief of pain following TFCC repair

The efficacy of intra-articular Ropivacaine for relief of pain following triangular fibrocartilage complex repair: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004600
Enrollment
34
Registered
2020-01-03
Start date
2019-12-23
Completion date
Unknown
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Experimental group: 30mg (4ml) of ropivacaine is injected via intra-articular manner after TFCC repair. Post-operatively, oral pain medication of Acetaminophen 650mg PO TID + Trama

Sponsors

Chung-Ang Univerisity Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient treated with arthroscopic triangular fibrocartilage comple repair for TFCC tear at the singe center

Exclusion criteria

Exclusion criteria: We excluded those with previous wrist surgery history, psychiatric illness, known allergy or contraindication to opioid or local anaesthetics, and those who regularly used narcotics and treated with other procedure combined with arthroscopic TFCC rrepair. Patients who wanted brachial plexus blockade or PCA after surgery were also excluded.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale by time measured from leaving of the recovery room

Secondary

MeasureTime frame
The number of fentanyl injection after surgery and the presence of nausea requiring medication

Countries

Korea, Republic of

Contacts

Public ContactHyoung Seok Jung

Chung-Ang Univerisity Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026